Logo FUNDABETS
Home
Candlestick Pattern Screener Chart Pattern Screener Custom Screener
Contact Us
Your Profile Settings Sign out
Home Candlestick Pattern Screener Chart Pattern Screener Custom Screener Contact Us
Tom Cook
tom@example.com
Your Profile Settings Sign out

Global Stocks Search

Help with searching

Search our entire platform for stocks by symbol, name, or exchange.

Navidea Biopharmaceuticals, Inc. (NAVB)

USD 0.0

(16.67%)

Overview Income Statements Balance Sheets Cash Flows Historical Prices Other

Eps Summary of Navidea Biopharmaceuticals, Inc.

  • Navidea Biopharmaceuticals, Inc.'s latest annual eps in 2022 was -0.59 USD , down -47.5% from previous year.
  • Navidea Biopharmaceuticals, Inc.'s latest quarterly eps in 2023 Q3 was -0.02 USD , down -118.92% from previous quarter.
  • Navidea Biopharmaceuticals, Inc. reported an annual eps of -0.40 USD in 2021, up 11.11% from previous year.
  • Navidea Biopharmaceuticals, Inc. reported an annual eps of -0.45 USD in 2020, up 40.79% from previous year.
  • Navidea Biopharmaceuticals, Inc. reported a quarterly eps of -0.02 USD for 2023 Q1, up 85.71% from previous quarter.
  • Navidea Biopharmaceuticals, Inc. reported a quarterly eps of -0.02 USD for 2023 Q3, down -118.92% from previous quarter.

Annual Eps Chart of Navidea Biopharmaceuticals, Inc. (2022 - 1992)

Historical Annual Eps of Navidea Biopharmaceuticals, Inc. (2022 - 1992)

Year Eps Eps Growth
2022 -0.59 USD -47.5%
2021 -0.40 USD 11.11%
2020 -0.45 USD 40.79%
2019 -0.76 USD 59.79%
2018 -1.89 USD -120.11%
2017 9.40 USD 610.87%
2016 -1.84 USD 49.59%
2015 -3.65 USD 23.96%
2014 -4.80 USD 31.53%
2013 -7.01 USD -19.02%
2012 -5.89 USD -590.83%
2011 1.20 USD 109.69%
2010 -12.38 USD -15.27%
2009 -10.74 USD -611.26%
2008 -1.51 USD 6.79%
2007 -1.62 USD 0.0%
2006 -1.62 USD 4.14%
2005 -1.69 USD -35.2%
2004 -1.25 USD -40.45%
2003 -0.89 USD 45.73%
2002 -1.64 USD -14360.87%
2001 0.01 USD -98.56%
2000 0.80 USD 122.04%
1999 -3.63 USD 85.21%
1998 -24.54 USD -20.0%
1997 -20.45 USD 3.4%
1996 -21.17 USD -36.14%
1995 -15.55 USD 34.11%
1994 -23.60 USD -4.42%
1993 -22.60 USD -175.61%
1992 -8.20 USD 0.0%
Year Eps Eps Growth
2023 Q2 0.12 USD 593.83%
2023 Q1 -0.02 USD 85.71%
2023 Q3 -0.02 USD -118.92%
2022 Q3 -0.19 USD -91.73%
2022 Q4 -0.17 USD 10.53%
2022 FY - USD -47.5%
2022 Q1 -0.10 USD 17.33%
2022 Q2 -0.10 USD 0.1%
2021 Q3 -0.08 USD 11.87%
2021 Q4 -0.12 USD -48.33%
2021 Q2 -0.09 USD 16.55%
2021 FY - USD 11.11%
2021 Q1 -0.11 USD 0.0%
2020 Q4 -0.11 USD 0.0%
2020 FY - USD 40.79%
2020 Q1 -0.13 USD 13.33%
2020 Q2 -0.10 USD 23.08%
2020 Q3 -0.11 USD -10.0%
2019 Q1 -0.24 USD 27.27%
2019 FY - USD 59.79%
2019 Q4 -0.15 USD 11.76%
2019 Q3 -0.17 USD 29.17%
2019 Q2 -0.24 USD 0.0%
2018 FY - USD -120.11%
2018 Q4 -0.33 USD 28.26%
2018 Q3 -0.46 USD -58.62%
2018 Q2 -0.29 USD 65.06%
2018 Q1 -0.83 USD -66.0%
2017 Q3 -0.18 USD 72.73%
2017 Q4 -0.50 USD -177.78%
2017 Q2 -0.66 USD -106.23%
2017 FY - USD 610.87%
2017 Q1 10.60 USD 2220.0%
2016 Q2 -0.86 USD -82.98%
2016 FY - USD 49.59%
2016 Q4 -0.50 USD -6478.95%
2016 Q3 -0.01 USD 99.12%
2016 Q1 -0.47 USD -46.87%
2015 FY - USD 23.96%
2015 Q4 -0.32 USD 70.09%
2015 Q2 -1.29 USD -32.99%
2015 Q3 -1.07 USD 17.05%
2015 Q1 -0.97 USD -5.43%
2014 Q3 -0.92 USD 32.35%
2014 Q2 -1.36 USD 16.05%
2014 FY - USD 31.53%
2014 Q1 -1.62 USD 20.98%
2014 Q4 -0.92 USD 0.0%
2013 FY - USD -19.02%
2013 Q4 -2.05 USD -9.63%
2013 Q2 -1.74 USD -34.88%
2013 Q3 -1.87 USD -7.47%
2013 Q1 -1.29 USD 6.52%
2012 FY - USD -590.83%
2012 Q4 -1.38 USD 22.47%
2012 Q3 -1.78 USD -44.72%
2012 Q2 -1.23 USD 17.45%
2012 Q1 -1.49 USD 8.02%
2011 Q2 -0.49 USD 52.88%
2011 FY - USD 109.69%
2011 Q4 -1.62 USD -138.57%
2011 Q3 4.20 USD 957.14%
2011 Q1 -1.04 USD -108.0%
2010 Q2 -10.73 USD -1630.65%
2010 Q3 -0.59 USD 94.5%
2010 Q4 -0.50 USD 15.25%
2010 FY - USD -15.27%
2010 Q1 -0.62 USD -740.11%
2009 FY - USD -611.26%
2009 Q4 -0.07 USD 98.9%
2009 Q2 -4.24 USD -2220.0%
2009 Q3 -6.72 USD -58.49%
2009 Q1 0.20 USD 157.14%
2008 Q3 -0.55 USD -83.33%
2008 Q2 -0.30 USD 0.0%
2008 Q1 -0.30 USD 47.37%
2008 Q4 -0.35 USD 36.36%
2008 FY - USD 6.79%
2007 FY - USD 0.0%
2007 Q4 -0.57 USD -90.0%
2007 Q3 -0.30 USD 18.92%
2007 Q2 -0.37 USD 0.0%
2007 Q1 -0.37 USD 15.91%
2006 Q1 -0.32 USD 27.27%
2006 FY - USD 4.14%
2006 Q3 -0.57 USD -96.55%
2006 Q2 -0.29 USD 9.38%
2006 Q4 -0.44 USD 22.81%
2005 FY - USD -35.2%
2005 Q2 -0.46 USD -35.29%
2005 Q4 -0.44 USD 0.0%
2005 Q3 -0.44 USD 4.35%
2005 Q1 -0.34 USD 56.96%
2004 Q1 -0.22 USD 0.0%
2004 Q2 -0.15 USD 31.82%
2004 Q3 -0.08 USD 45.2%
2004 Q4 -0.79 USD -861.07%
2004 FY - USD -40.45%
2003 Q1 -0.25 USD -190.36%
2003 FY - USD 45.73%
2003 Q4 -0.22 USD 35.29%
2003 Q3 -0.34 USD -723.24%
2003 Q2 -0.04 USD 83.48%
2002 Q2 -0.48 USD -2.13%
2002 Q1 -0.47 USD -30.56%
2002 FY - USD -14360.87%
2002 Q4 -0.09 USD 85.65%
2002 Q3 -0.60 USD -25.0%
2001 Q3 0.40 USD 100.0%
2001 FY - USD -98.56%
2001 Q2 0.20 USD 219.49%
2001 Q1 0.06 USD -88.82%
2001 Q4 -0.36 USD -190.0%
2000 Q4 0.56 USD 40.0%
2000 Q2 0.40 USD 1986.79%
2000 Q1 -0.02 USD -109.64%
2000 FY - USD 122.04%
2000 Q3 0.40 USD 0.0%
1999 Q3 -1.46 USD -21.67%
1999 Q2 -1.20 USD -6.19%
1999 Q4 0.22 USD 115.07%
1999 Q1 -1.13 USD 87.07%
1999 FY - USD 85.21%
1998 Q4 -8.74 USD -82.08%
1998 Q1 -6.20 USD -18.1%
1998 FY - USD -20.0%
1998 Q2 -4.60 USD 25.81%
1998 Q3 -4.80 USD -4.35%
1997 Q2 -6.40 USD -52.38%
1997 Q4 -5.25 USD -9.38%
1997 Q3 -4.80 USD 25.0%
1997 FY - USD 3.4%
1997 Q1 -4.20 USD 47.17%
1996 FY - USD -36.14%
1996 Q4 -7.95 USD -89.29%
1996 Q3 -4.20 USD 4.55%
1996 Q2 -4.40 USD -10.0%
1996 Q1 -4.00 USD 5.21%
1995 Q3 -3.20 USD 11.11%
1995 Q4 -4.22 USD -31.87%
1995 FY - USD 34.11%
1995 Q2 -3.60 USD 14.29%
1995 Q1 -4.20 USD 38.14%
1994 FY - USD -4.42%
1994 Q1 -6.20 USD -1.81%
1994 Q2 -5.00 USD 19.35%
1994 Q3 -8.00 USD -60.0%
1994 Q4 -6.79 USD 15.13%
1993 Q4 -6.09 USD -17.12%
1993 Q2 -4.80 USD -60.0%
1993 Q3 -5.20 USD -8.33%
1993 FY - USD -175.61%
1993 Q1 -3.00 USD -26.58%
1992 FY - USD 0.0%
1992 Q3 -2.60 USD 0.0%
1992 Q4 -2.37 USD 8.85%

Peer Eps Comparison of Navidea Biopharmaceuticals, Inc.

Name Eps Eps Difference
America Great Health - USD Infinity%
Ampio Pharmaceuticals, Inc. -10.67 USD 94.47%
Aridis Pharmaceuticals, Inc. -1.64 USD 64.024%
Biora Therapeutics, Inc. -7.87 USD 92.503%
Bio-Path Holdings, Inc. -33.64 USD 98.246%
Better Therapeutics, Inc. -1.69 USD 65.089%
Calithera Biosciences, Inc. -7.94 USD 92.569%
Comera Life Sciences Holdings, Inc. -1.76 USD 66.477%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -16.37 USD 96.396%
Eloxx Pharmaceuticals, Inc. -16.65 USD 96.456%
Evelo Biosciences, Inc. -26.28 USD 97.755%
Evolutionary Genomics, Inc. -0.35 USD -68.571%
Finch Therapeutics Group, Inc. -46.59 USD 98.734%
Galera Therapeutics, Inc. -1.33 USD 55.639%
Innovation1 Biotech Inc. -0.70 USD 15.714%
Kiromic BioPharma, Inc. -21.41 USD 97.244%
Molecular Templates, Inc. -1.80 USD 67.222%
NexImmune, Inc. -30.82 USD 98.086%
Orgenesis Inc. -1.91 USD 69.11%
Panbela Therapeutics, Inc. -232.42 Thousand USD 100.0%
Point of Care Nano-Technology, Inc. -0.10 USD -490.0%
PaxMedica, Inc. Common Stock -11.00 USD 94.636%
Scopus BioPharma Inc. -0.55 USD -7.273%
Sorrento Therapeutics, Inc. -1.37 USD 56.934%
Statera Biopharma, Inc. -4.97 USD 88.129%
TRACON Pharmaceuticals, Inc. -2.20 USD 73.182%
Trevena, Inc. -54.51 USD 98.918%
Vaxxinity, Inc. -0.45 USD -31.111%
Vaccinex, Inc. -43.68 USD 98.649%
Vicapsys Life Sciences, Inc. -0.03 USD -1625.146%
Viracta Therapeutics, Inc. -1.32 USD 55.303%
ZIVO Bioscience, Inc. -4.60 USD 87.174%
About
Contact
FAQs